Last reviewed · How we verify

NCT06806384

Effects of Cognitive-Motor Exergame Using Dividat Senso on Physical and Cognitive Function in Stroke Patients

Completed NA Last updated 6 February 2025
What this trial tests

NA trial testing ExerGame-based Stroke Rehabilitation in Stroke in 26 participants. Completed in 31 March 2024.

Timeline
7 October 2023
Primary endpoint
28 February 2024
31 March 2024

Quick facts

Lead sponsorSahmyook University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment26
Start date7 October 2023
Primary completion28 February 2024
Estimated completion31 March 2024
Sites1 location across South Korea

Drugs / interventions tested

Conditions studied

Sponsor

Sahmyook University

Who can join

Eligibility, any sex, with Stroke. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this randomized controlled trial is to assess whether exergaming using the Dividat Senso platform more effectively enhances physical and cognitive functions in patients with chronic stroke compared to standard balance exercises. The primary questions it seeks to answer are: * Does exergaming with the Dividat Senso lead to greater improvements in physical function, as measured by outcomes such as the Functional Gait Assessment and the Short Physical Performance Battery? * Does exergaming with the Dividat Senso result in greater enhancements in cognitive function, evaluated through measures such as the Trail Making Test (Parts A and B) and the Stroop Test? Researchers will compare two groups: * An ExerGame group, receiving exergaming with the Dividat Senso in addition to standard rehabilitation. * A Control group, receiving standard balance exercises. Participants will: * Undergo a four-week training period, consisting of five sessions per week, with each session lasting 30 minutes. * Receive standard rehabilitation, including neurodevelopmental treatment and occupational therapy, alongside their assigned balance or exergame exercises. * Complete baseline and post-intervention assessments of physical function (using the Functional Gait Assessment and the Short Physical Performance Battery) and cognitive function (using the Trail Making Test and the Stroop Test). * During each exergame session, participants in the ExerGame group will interact with the Dividat Senso platform, performing weight-shifting, stepping, and task-oriented balancing exercises guided by real-time feedback on a virtual interface. * Participants in the Control group will perform standard balance exercises emphasizing weight transfer in anterior-posterior and medial-lateral directions. This study aims to clarify the efficacy of exergaming as a dual-task intervention for chronic stroke rehabilitation, potentially offering a more engaging and effective approach to improving both motor and cognitive functions.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Dual‑task exergaming to enhance motor and cognitive function in chronic stroke: a prospective, assessor-blinded, parallel group randomized controlled trial.
    Jo S, Kim H, Song C. · · 2026 · PMID 41715216 · DOI 10.1186/s12984-026-01913-y

Verify or expand the search:

Other recruiting trials for Stroke

Currently open trials in the same condition.

Other Sahmyook University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06806384.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing